TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34981324

Group type: EXPERIMENTAL
Intervention: Long biliopancreatic Roux-en-Y gastric bypass (L-RYGB)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard Roux-en-Y gastric bypass (S-RYGB)
Number of subjects: 150
Study: 35303017

Group type: EXPERIMENTAL
Intervention: Supervised multimodal exercise training (3x/week for 12 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (physically inactive)
Number of subjects: 42
Study: 35253836

Group type: COMPARATOR
Intervention: Left dorsolateral prefrontal cortex (DLPFC) stimulation (1 mA, 20 min)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Right dorsolateral prefrontal cortex (DLPFC) stimulation (1 mA, 20 min)
Number of subjects: 254
Study: 32592273

Group type: EXPERIMENTAL
Intervention: Q switched KTP (532 nm) laser
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intra-dermal tranexamic acid (TXA) injections
Number of subjects: 30
Study: 36018124

Group type: EXPERIMENTAL
Intervention: Atropine 0.01% eye drops applied at night
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33220216

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment with dihydroartemisinin-piperaquine
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Single screening and treatment with dihydroartemisinin-piperaquine
Number of subjects: 1000
Study: 36049700

Group type: EXPERIMENTAL
Intervention: High-dose MVC-COV1901 (25 mcg)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Mid-dose MVC-COV1901 (15 mcg)
Number of subjects: 420
Study: 34331403

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nuts (50 g day-1)
Number of subjects: 50
Study: 32580577

Group type: EXPERIMENTAL
Intervention: Simplified multilayer bandage
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cohesive bandage
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Kinesio-tape
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Adhesive bandage
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Multilayer bandage
Number of subjects: 150
Study: 36195982

Group type: EXPERIMENTAL
Intervention: Text message interventions (1-2 messages in the 3 days preceding appointment)
Number of subjects: 74811

Group type: EXPERIMENTAL
Intervention: Top performing text message (described vaccine as 'reserved for you')
Number of subjects: 74811

Group type: EXPERIMENTAL
Intervention: Other interventions
Number of subjects: 74811
Study: 33460240

Group type: EXPERIMENTAL
Intervention: iACT (Internet-delivered acceptance and commitment therapy)
Number of subjects: 113

Group type: COMPARATOR
Intervention: waitlist (control group)
Number of subjects: 113
Study: 36200056

Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (once-a-week)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (thrice-a-week)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity walking (once-a-week)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Vigorous-intensity walking (thrice-a-week)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Stretching exercise (Control group)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Walking exercise groups (all types)
Number of subjects: 37
Study: 32872077

Group type: EXPERIMENTAL
Intervention: Yiqi Huayu Jiedu decoction
Number of subjects: 226
Study: 34748469

Group type: EXPERIMENTAL
Intervention: Classroom-based active breaks intervention
Number of subjects: 146
Study: 35760497

Group type: EXPERIMENTAL
Intervention: QUT Inspire app
Number of subjects: 24

Group type: COMPARATOR
Intervention: Triflo II clinical ISy device
Number of subjects: 24
Study: 32700215

Group type: EXPERIMENTAL
Intervention: Community-based diabetes self-management education (DSME) plus 6 months of mHealth-enhanced peer support (12 weekly phone calls, then 3 monthly calls)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Community-based diabetes self-management education (DSME) alone
Number of subjects: 120
Study: 34145517

Group type: EXPERIMENTAL
Intervention: Patient Mania Questionnaire-9 (PMQ-9)
Number of subjects: 179
Study: 33832054

Group type: EXPERIMENTAL
Intervention: Extended depth of focus contact lenses
Number of subjects: 30
Study: 32270891

Group type: EXPERIMENTAL
Intervention: HIT-RT exercise group (EG; n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (CG; n = 22)
Number of subjects: 43
Study: 33452181

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg two times a day
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg two times a day
Number of subjects: 710

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Tofacitinib (both dosages)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 710
Study: 34835098

Group type: COMPARATOR
Intervention: Placebo group from a historic randomized controlled trial of ganciclovir for early treatment of CMV infection.
Number of subjects: 0
Study: 33017168

Group type: EXPERIMENTAL
Intervention: Lateral extra-articular tenodesis (LET) during simulated pivoting loads
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Lateral extra-articular tenodesis (LET) during simulated anterior drawer test
Number of subjects: 7

Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (without LET)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Simulated Lachman test with LET
Number of subjects: 7

Group type: COMPARATOR
Intervention: Simulated Lachman test without LET
Number of subjects: 7
Study: 35367806

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (PREx), 24 sessions over 2 months, 3 sets of 8-10 repetitions of 8 whole-body exercises at moderate intensity
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (PREx)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study: 34106081

Group type: EXPERIMENTAL
Intervention: SMS text message program for supporting self-management (Text4HeartII) for 24 weeks plus usual cardiac services
Number of subjects: 306

Group type: COMPARATOR
Intervention: usual cardiac services
Number of subjects: 306
Study: 33147073

Group type: EXPERIMENTAL
Intervention: Wearable respiratory monitor with daily in-application breathing exercise for 30 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group received psychoeducation after completion of the study
Number of subjects: 65
Study: 35512340

Group type: EXPERIMENTAL
Intervention: Low linoleic acid foods with added DHA
Number of subjects: 559

Group type: COMPARATOR
Intervention: HO-RUTF (High Oleic Acid Ready-to-Use Therapeutic Food)
Number of subjects: 559

Group type: COMPARATOR
Intervention: S-RUTF (Standard Ready-to-Use Therapeutic Food)
Number of subjects: 559
Study: 32139409

Group type: EXPERIMENTAL
Intervention: Vitamin C (6000 mg/day)
Number of subjects: 1444

Group type: COMPARATOR
Intervention: Placebo (0 mg/day)
Number of subjects: 1444
Study: 34011376

Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity (MVPA)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Female gender (versus males)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Obese weight status (versus non-obese)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Teaching in a middle school (versus elementary)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Light physical activity (LPA)
Number of subjects: 288
Study: 32854975

Group type: EXPERIMENTAL
Intervention: Negative air ions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Particulate matter exposure
Number of subjects: 0
Study: 35357352

Group type: EXPERIMENTAL
Intervention: Surgical ligation (SL)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cardiac catheter-based closure (CCC)
Number of subjects: 69
Study: 34431380

Group type: EXPERIMENTAL
Intervention: Self-reported loneliness assessment
Number of subjects: 4588

Group type: EXPERIMENTAL
Intervention: Demographic and health-related factors
Number of subjects: 4588
Study: 35484697

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg + TCS
Number of subjects: 463

Group type: COMPARATOR
Intervention: Placebo + TCS
Number of subjects: 463
Study: 33563084

Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer
Number of subjects: 0
Study: 32186160

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (30-minute sessions, 3 times weekly for 6 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Routine conventional Western Medicine treatment alone
Number of subjects: 102
Study: 35252408

Group type: EXPERIMENTAL
Intervention: Sutureless aortic valve replacement (Su-AVR)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Standard aortic valve replacement (SAVR)
Number of subjects: 819
Study: 33126692

Group type: EXPERIMENTAL
Intervention: Tunnelled intervention (N = 27)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Free-choice intervention (N = 27)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Minimal intervention control (N = 17)
Number of subjects: 71
Study: 34400207

Group type: EXPERIMENTAL
Intervention: Enrolled in HEAL trial
Number of subjects: 269

Group type: COMPARATOR
Intervention: Declined enrollment in HEAL trial
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Enrolled parents
Number of subjects: 269

Group type: COMPARATOR
Intervention: Declined parents
Number of subjects: 269
Study: 32325415

Group type: EXPERIMENTAL
Intervention: Static Stretch with Vibration (SV)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Static Stretch (SS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normative (N)
Number of subjects: 39
Study: 35106617

Group type: EXPERIMENTAL
Intervention: TDM-guided therapy (continuous infusion of piperacillin/tazobactam with dosing guided by daily TDM)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Fixed dose therapy (continuous infusion of piperacillin/tazobactam at 13.5 g/24 h if eGFR ≥ 20 mL/min)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: TDM-guided therapy
Number of subjects: 254

Group type: COMPARATOR
Intervention: Fixed dose therapy
Number of subjects: 254
Study: 33909732

Group type: EXPERIMENTAL
Intervention: Implant survival probability for patients ≤ 70 years of age
Number of subjects: 378

Group type: COMPARATOR
Intervention: Sex
Number of subjects: 378

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 378

Group type: COMPARATOR
Intervention: Diabetes
Number of subjects: 378

Group type: COMPARATOR
Intervention: Arch location
Number of subjects: 378
Study: 35351531

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole prophylaxis
Number of subjects: 2848

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2848
Study: 33829551

Group type: EXPERIMENTAL
Intervention: Single-operator cholangioscopy-guided biopsy (SpyGlassDS)
Number of subjects: 100
Study: 33248581

Group type: EXPERIMENTAL
Intervention: ZnSO4 treatment: 80 mg zinc/kg from ZnSO4
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: ISO treatment: 40 mg zinc/kg from ZnSO4 plus 40 mg zinc/kg from a zinc-amino acid complex
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Organic treatment: 40 mg zinc/kg from a zinc-amino acid complex
Number of subjects: 180
Study: 36427446

Group type: EXPERIMENTAL
Intervention: Video version 1
Number of subjects: 4697

Group type: EXPERIMENTAL
Intervention: Video version 2
Number of subjects: 4697

Group type: COMPARATOR
Intervention: Positively framed videos
Number of subjects: 4697

Group type: COMPARATOR
Intervention: Negatively framed videos
Number of subjects: 4697
Study: 35648794

Group type: EXPERIMENTAL
Intervention: Rupatadine 40mg for 5 days
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 249
Study: 35301592

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 0
Study: 34375844

Group type: EXPERIMENTAL
Intervention: Random schedule of practice
Number of subjects: 84

Group type: COMPARATOR
Intervention: Blocked schedule of practice
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Error estimation
Number of subjects: 84

Group type: COMPARATOR
Intervention: No error estimation
Number of subjects: 84
Study: 32759193

Group type: EXPERIMENTAL
Intervention: Vitamin D 400 IU and 500 mg of calcium carbonate twice a day for 1 year
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Observation group (no vitamin D evaluation or supplementation)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation
Number of subjects: 1050
Study: 33277370

Group type: EXPERIMENTAL
Intervention: GVAX alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: GVAX with low-dose oral cyclophosphamide
Number of subjects: 87

Group type: COMPARATOR
Intervention: Historical controls who received adjuvant GVAX alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Higher density of intratumoral tertiary lymphoid aggregates (TLA)
Number of subjects: 87
Study: 33525212

Group type: EXPERIMENTAL
Intervention: SOF/LDP 400/100 mg daily plus standard of care (n=42)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard of care alone (control group, n=40)
Number of subjects: 82
Study: 33781620

Group type: EXPERIMENTAL
Intervention: 100 Mile Club
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Just Move
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1008
Study: 33348685

Group type: EXPERIMENTAL
Intervention: 280 g/day of frozen raspberries for 8 weeks
Number of subjects: 59

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 59
Study: 35512068

Group type: EXPERIMENTAL
Intervention: α lipoic acid combined with olmesartan medoxomil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olmesartan medoxomil combined with placebo
Number of subjects: 0
Study: 33862811

Group type: EXPERIMENTAL
Intervention: Local logarithmic export distributions by destinations and products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Out-degree of the exporter and in-degrees of destinations or products
Number of subjects: 0
Study: 34023888

Group type: EXPERIMENTAL
Intervention: Nurse-led alcohol guidance intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 32062021

Group type: EXPERIMENTAL
Intervention: Fitspiration images
Number of subjects: 108

Group type: COMPARATOR
Intervention: Travel inspiration images
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Exercise following fitspiration images
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Quiet rest following fitspiration images
Number of subjects: 108
Study: 35660514

Group type: EXPERIMENTAL
Intervention: Situation-focused reappraisal
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Self-focused reappraisal
Number of subjects: 44
Study: 34564920

Group type: EXPERIMENTAL
Intervention: Virtual Learning Object (VLO) for undergraduate dental students (VLOG)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Synchronous virtual class (Control Group - CG)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Virtual Learning Object (VLO) for paediatric dentists (PDG)
Number of subjects: 220
Study: 32037583

Group type: EXPERIMENTAL
Intervention: Web-based virtual patient training (n=36)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Face-to-face case-based training (n=40)
Number of subjects: 76
Study: 35512619

Group type: EXPERIMENTAL
Intervention: BST stimulation (left, right, bilateral)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 9
Study: 35984916

Group type: EXPERIMENTAL
Intervention: Staying Strong & Healthy intervention (education, exercise, and nutrition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study: 36395521

Group type: EXPERIMENTAL
Intervention: Open-source ultrasound trainer (OSUT) in addition to an ultrasound system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ultrasound system (control group)
Number of subjects: 24
Study: 34182749

Group type: EXPERIMENTAL
Intervention: AFCNB + FTB
Number of subjects: 80

Group type: COMPARATOR
Intervention: FTB
Number of subjects: 80
Study: 32751720

Group type: EXPERIMENTAL
Intervention: Dynamic Core Exercise (DCE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: General Physical Education (GPE)
Number of subjects: 52
Study: 34837121

Group type: EXPERIMENTAL
Intervention: Probiotic treatment 14 days prior to surgery
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 32164634

Group type: EXPERIMENTAL
Intervention: Within-category lower calorie labels
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Across-category lower calorie labels
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control (no labeling)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Within-category lower calorie labels (beverages)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Across-category lower calorie labels (beverages)
Number of subjects: 146
Study: 35416793

Group type: EXPERIMENTAL
Intervention: Pickle juice
Number of subjects: 82

Group type: COMPARATOR
Intervention: Tap water (Control)
Number of subjects: 82
Study: 33992656

Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI)
Number of subjects: 11701
Study: 33186867

Group type: EXPERIMENTAL
Intervention: Descriptive research
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Predictive research
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Explanatory research
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Research designs
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Alternative techniques
Number of subjects: 100
Study: 35152536

Group type: EXPERIMENTAL
Intervention: Intralesional injection of vitamin D3 (1ml every 4 weeks for a maximum of 3 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline 0.9% (control group, 1ml every 4 weeks for 3 sessions)
Number of subjects: 60
Study: 32991361

Group type: EXPERIMENTAL
Intervention: Cervical Disk Arthroplasty (CDA)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Control (Preoperative condition)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Postoperative condition at 10 years
Number of subjects: 397
Study: 36118833

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) combined with Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 92
Study: 32409691

Group type: EXPERIMENTAL
Intervention: isatuximab 3 mg/kg every 2 weeks (Q2W)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: isatuximab 10 mg/kg Q2W/Q4W
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: isatuximab 10 mg/kg Q2W
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: isatuximab 20 mg/kg QW(1 cycle)/Q2W
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: isatuximab (doses ≥10 mg/kg)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: non-hematologic adverse events
Number of subjects: 97
Study: 36364803

Group type: EXPERIMENTAL
Intervention: R24W
Number of subjects: 68

Group type: COMPARATOR
Intervention: ASA24-Canada-2018
Number of subjects: 68

Group type: COMPARATOR
Intervention: R24W and ASA24-Canada-2018
Number of subjects: 68
Study: 33087074

Group type: EXPERIMENTAL
Intervention: Telemedicine follow-up care
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard outpatient care
Number of subjects: 182
Study: 32090656

Group type: EXPERIMENTAL
Intervention: Collective venue avoidance through social mechanisms (homophily and popular opinion leaders)
Number of subjects: 468
Study: 33969614

Group type: EXPERIMENTAL
Intervention: Mifepristone and misoprostol
Number of subjects: 711

Group type: COMPARATOR
Intervention: Misoprostol alone (placebo)
Number of subjects: 711
Study: 32961119

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks for four doses, then every 12 weeks until 1 year or until disease recurrence, unacceptable toxicity, or withdrawal)
Number of subjects: 906

Group type: COMPARATOR
Intervention: Ipilimumab (10 mg/kg every 3 weeks for four doses, then every 12 weeks until 1 year or until disease recurrence, unacceptable toxicity, or withdrawal)
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 906

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 906
Study: 36462120

Group type: EXPERIMENTAL
Intervention: Weight Regain (WR) group (Group A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Weight Loss group (Group B)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 88
Study: 34049396

Group type: EXPERIMENTAL
Intervention: Higher carbohydrate diets (58% kcal)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Lower carbohydrate diets (40% kcal)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Higher GI diets (≥65)
Number of subjects: 163
Study: 33408120

Group type: EXPERIMENTAL
Intervention: +F+H
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: +F-H
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: -F+H
Number of subjects: 88

Group type: COMPARATOR
Intervention: -F-H
Number of subjects: 88
Study: 34000629

Group type: EXPERIMENTAL
Intervention: Weight-bearing progressive resistive quadriceps exercise
Number of subjects: 17

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 17
Study: 36251472

Group type: EXPERIMENTAL
Intervention: Nasal-tragus length based formula (NTL + 1 cm)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Weight based formula (Weight + 6 cm)
Number of subjects: 120
Study: 33259001

Group type: EXPERIMENTAL
Intervention: UFT
Number of subjects: 689

Group type: COMPARATOR
Intervention: CMF
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: TILs high
Number of subjects: 689
Study: 36174848

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (60,000 IU of vitamin D3 once per month for up to 5 years)
Number of subjects: 19925

Group type: COMPARATOR
Intervention: Placebo (oral once per month for up to 5 years)
Number of subjects: 19925

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 19925

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19925
Study: 33977364

Group type: EXPERIMENTAL
Intervention: ModelCI (combination of clinical factors and imaging characteristics)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: ModelC (clinical factors)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: ModelI (imaging characteristics)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Risk score ≥ 0.88 (high-risk subgroup)
Number of subjects: 185